Axon Enterprise (AXON) traded lower on April 29, 2026, down roughly 5% to around $380, as investors rotated out of the stock ahead of the company’s next earnings catalyst. The key near-term event is Axon’s first-quarter 2026 results, due after the market closes on May 6, which is prompting pre-earnings repositioning rather than a reaction to a new operational headline. (marketbeat.com)

Market expectations center on Q1 EPS of about $1.60 and revenue near $778 million, and with the report one week away, even modest uncertainty can pressure a high-multiple name on down days. In that setup, incremental sellers often include short-term holders locking in gains or reducing exposure into a binary event. (marketbeat.com)

Axon has been volatile in 2026 as investors debate how much growth is already priced in, and recent commentary has highlighted concerns that the stock had been valued for near-perfect execution. Separately, the company disclosed in an April 10 filing that director Matthew McBrady will not stand for re-election at the 2026 annual meeting—an item that can add to headline sensitivity even if it does not change fundamentals. (tikr.com)

The next decisive driver is May 6 guidance and the trajectory of software/recurring revenue, bookings, and margins versus expectations. Any commentary on litigation/contingencies and spending levels could also influence how investors value the business immediately after the print. (morningstar.com)